Meningococcal Infection
📧 Sign up to get email alerts when something new happens for Meningococcal Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-10Clinical Trial Update: Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years [Phase 3]
Phase 3 trial update for a meningococcal conjugate vaccine (Group ACYW135) in children aged 2-6 years; status is active not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China [Phase 3]
An investigational quadrivalent meningococcal conjugate vaccine is being studied for immunogenicity and safety in healthy children and adole…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in Vietnam [Phase 3]
Phase 3 study evaluating a MenACYW quadrivalent meningococcal conjugate vaccine administered as a single dose to participants aged 12 months…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom [Phase 3]
Phase 3 trial assessing immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine in infants and toddlers when given with …
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico [Phase 3]
Phase 3 trial assessing safety and immunogenicity of a quadrivalent meningococcal vaccine given with routine pediatric vaccines in healthy i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers [Phase 3]
Phase 3 trial update assessing safety of a quadrivalent meningococcal conjugate vaccine given with routine pediatric vaccines in healthy inf…
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49 [Phase 3]
Phase 3 update evaluating safety and immunogenicity of a single-dose MenACYW meningococcal conjugate vaccine booster in older adults who com…
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adults 18 to 40 Years of Age [Phase 2]
Phase 2 trial assessing safety and immunogenicity of different formulations of a meningococcal ACWY vaccine in healthy adults aged 18-40; st…
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers [Phase 2]
Phase 2 trial update for a quadrivalent meningococcal tetanus protein conjugate vaccine in infants and toddlers; study completed with result…
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose [Phase 3]
Phase 3 trial update assessing duration of hSBA response after a primary series of bivalent rLP2086 with a booster dose.
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents [Phase 2]
Phase 2 study assessing long-term immunological persistence and response to a booster after GSK meningococcal ABCWY vaccination in adolescen…
-
CLINICAL_TRIALS trial_result · 2019-08-06Clinical Trial Update: Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers [Phase 3]
Phase 3 trial update on immunogenicity and safety of GSK meningococcal conjugate vaccine when co-administered with routine vaccines in healt…
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: The Long-term Antibody Persistence of MenACWY-TT Vaccine (PF-06866681) Versus Meningitec(Registered) or Mencevax(Registered) ACWY in Healthy Adolescents and Adults and a Booster Dose of MenACWY-TT Administered 10 Years Post Primary Vaccination [Phase 3]
A Phase 3 trial comparing long-term antibody persistence of MenACWY-TT vaccine to licensed ACWY vaccines, including a booster at 10 years, i…
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: Safety and Immunogenicity of an Aluminium Hydroxide/LHD153R Adjuvanted Meningococcal C-CRM197 Conjugate Vaccine [Phase 1]
Phase 1 trial assessing safety and immunogenicity of an aluminium hydroxide/LHD153R adjuvanted Meningococcal C-CRM197 conjugate vaccine; com…
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life [Phase 4]
A Phase 4 clinical trial evaluated immune responses and antibody persistence in UK infants receiving multiple vaccines, including boosters i…
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years [Phase 2]
Phase 2 study assessing immunogenicity, safety, and tolerability of the bivalent recombinant lipoprotein 2086 vaccine against meningococcal …
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation [Phase 3]
Phase 3 trial assessing immunogenicity and safety of Menactra vaccine in children aged 9 to 23 months in India and Russia; study completed w…
-
CLINICAL_TRIALS trial_result · 2016-11-11Clinical Trial Update: Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to Children
Post-licensure safety surveillance study of Menactra given as a two-dose schedule to children; the study has completed and results were post…
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study
Follow-up results show the persistence of protective antibody titers 12-24 months after NmVac4-A/C/Y/W-135-DT vaccination.
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age [Phase 4]
Phase 4 clinical trial update on Menactra in healthy infants at 9 months and co-administered with Pentacel at 15-18 months; results have bee…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Safety and Immunogenicity in Dose-Ranging and Formulation-Finding Meningococcal B (MenB) Vaccine Study in 2-month-old Infants [Phase 2]
Phase 2 study evaluating safety and immunogenicity of a meningococcal B vaccine in 2-month-old infants. Results were completed and posted in…
-
CLINICAL_TRIALS trial_result · 2014-11-18Clinical Trial Update: Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine [Phase 2]
A Phase 2 study evaluated a single dose of Menactra given 4-6 years after prior Menactra vaccination; the trial is completed and results wer…
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: Immunogenicity of the Booster Dose of Two MenC Vaccines [Phase 4]
Phase 4 trial update evaluating the immunogenicity of booster doses for two Meningococcal C vaccines; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants [Phase 3]
A Phase 3 trial evaluating the safety of the Novartis MenACWY Conjugate Vaccine when administered with routine infant vaccinations in health…
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients [NA]
A completed clinical trial from University of Colorado evaluated adolescent vaccination reminder/recall systems, focusing on HPV, meningococ…